SNHG17 and renal carcinoma: The expression of DOCK8-AS1 (Figure 1D) was significantly decreased, while the expressions of SNHG17, RUSC1-AS1, LINC02609, and LUCAT1 (Figure 1D) were increased significantly in patients with renal cancer.